Industry Reports
Lexicon Pharmaceuticals acquires exclusive rights to development candidate for Neuropathic pain from its alliance with Bristol-Myers Squibb
Lexicon Pharmaceuticals Inc announced that it has obtained exclusive research, development and commercialization rights to LX9211 (BMS-986176), a development candidate for neuropathic pain that was jointly developed by Lexicon and Bristol-Myers Squibb Company as part of their neuroscience drug...
Industry Reports
Medivir strengthens its clinical pipeline by entering into agreement to acquire a portfolio of clinical stage oncology programs
Medivir AB announces that it has entered into an agreement to acquire two clinical stage oncology programs from Tetralogic Pharmaceuticals Corporation , advancing and expanding its clinical pipeline. The acquisition includes remetinostat, a skin-directed HDAC inhibitor,...
Industry Reports
Aralez Completes Acquisition Of Toprol-XL Â And Its Authorized Generic From AstraZeneca
Aralez Pharmaceuticals Inc a global specialty pharmaceutical company announced that its subsidiary, Aralez Pharmaceuticals Trading DAC (Aralez Ireland), has completed its acquisition of the U.S. rights to Toprol-XL® (metoprolol succinate) and its Authorized Generic (AG) from AstraZeneca. ...
Industry Reports
IMS Health and Quintiles Transnational Holdings Merge completed
Quintiles IMS Holdings has successfully completed its merger of equals transaction between IMS Health Holdings and Quintiles Transnational Holdings. The merger of IMS Health, a global information and technology services company, and Quintiles, a provider of...
Industry Reports
ICU Medical to acquire the Hospira Infusion Systems Business from Pfizer for $1B
ICU Medical will acquire all of Pfizer’s global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock. The Hospira Infusion Systems business includes IV pumps, solutions, and devices that, when combined...
Industry Reports
PAREXEL Announces Execution of Definitive Agreement to Acquire ExecuPharm
PAREXEL International Corporation , a leading global biopharmaceutical services provider announced that the Company has entered into a definitive agreement to acquire ExecuPharm, Inc , a leading, global functional service provider (FSP) serving the biopharmaceutical industry. ...
Industry Reports
Teva Completes Acquisition of Anda, Inc
Teva Pharmaceutical Industries Ltd announced that it has completed its acquisition of Anda, Inc., a leading distributor of generic pharmaceuticals in the U.S., from Allergan plc. “We are pleased that Anda, Inc., one of the leading...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
